![David Kendall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 680 646 $ in data 31/07/2026
David M.
Kendall currently works at Zealand Pharma A, as Chief Medical Officer from 2022.
Dr. Kendall also formerly worked at Amylin Pharmaceuticals, Inc., as Medical Director from 2005 to 2008, Park Nicollet Health Services, as Director & Medical Director from 1994 to 1997, International Diabetes Center, as Medical Director from 1997 to 2009, Eli Lilly & Co., as Vice President-Global Medical Affairs from 2011 to 2018, MannKind Corp., as Chief Medical Officer from 2018 to 2020, American Diabetes Association, as Chief Scientific & Medical Affairs Officer from 2009 to 2011, and Lilly Diabetes, as Vice President-Global Medical Affairs from 2011 to 2018.
Dr. Kendall received his undergraduate degree in 1983 from St. Olaf College and doctorate degree in 1988 from the University of Minnesota.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,02% | 31/12/2025 | 14.546 ( 0,02% ) | 680 646 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ZEALAND PHARMA A/S | Direttore Tecnico/Scientifico/R&S | 02/06/2022 |
| Società | Posizione | Fine |
|---|---|---|
| MANNKIND CORPORATION | Direttore Tecnico/Scientifico/R&S | 28/08/2020 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/02/2018 |
Lilly Diabetes | Corporate Officer/Principal | 01/01/2018 |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Direttore Tecnico/Scientifico/R&S | 01/07/2011 |
International Diabetes Center
 International Diabetes Center Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit health care organization that provides diabetic treatment and research services | Direttore Tecnico/Scientifico/R&S | 01/09/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
MannKind Corp.
 MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
St. Olaf College
 St. Olaf College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
Park Nicollet Health Services
 Park Nicollet Health Services Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
International Diabetes Center
International Diabetes Center Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit health care organization that provides diabetic treatment and research services | Commercial Services |
Lilly Diabetes |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
